VATupdate

Share this post on

Legislative proposal with financial impact for pharma companies: VAT adjustment for certain contributions

A draft normative act recently published by the Ministry of Finance regulates the possibility for economic agents to reduce the VAT tax base with price reductions that are not granted directly to customers in the commercial chain, but which have the effect of reducing the price paid by the final consumer. The impact will be felt especially in the pharmaceutical industry, it is stated in the statement of reasons of the draft normative act, the authorities’ estimate being that the budgetary effect will be minus 290 million lei as a result of this legislative change.

Source: blog.pwc.ro

Sponsors:

VAT news

Advertisements: